// App-Quantinova.ai

: Ensifentrine added on to tiotropium significantly improves lung function, symptoms and QoL in symptomatic COPD patients regardless of baseline reversibility

Researchers

Presenter

  • Kathleen Rickard

Principal Investigators

  • Thomas Bengtsson

  • Tara Rheault

Medical Centers

  • Topivert Pharma, London, United Kingdom

  • StatMind AB, Lund, Sweden.

Locations

  • United Kingdom

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • Tiotropium bromide

  • Carbocysteine

  • RPL554

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved